Latest Updates

The R&D investments in the quarter ramped up to ~7.6 per cent of revenues Cipla Limited announced its audited consolidated…

CPhI Conferences will host the ‘The 3rd edition of The India Packaging Awards’ on 24th May 2018

Ryaltris is for seasonal allergic rhinitis and it is formerly known as GSP 301 nasal spray, and it is the company’s leading…

There are only nine biosimilars available on the US market to date and it is estimated that only three per cent of spending on…

Organised by Clarivate Analytics, it honours India’s most disruptive innovators

The company has already commenced supplies of the product to the US market

CDSCO website will release a notification about the new provision for sale of medicines in India

Manufacturing facilities at Patalganga and Rabale were inspected successfully

Revenues were at Rs 6,775 million in Q4 FY18

Cipla will get exclusive marketing rights for five years in India for critical limb ischemia due to atherosclerotic peripheral…